Macpod O 200 mg/200 mg Tablet is a combination antibiotic formulation containing Cefpodoxime Proxetil 200 mg and Ofloxacin 200 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefpodoxime Proxetil, a third-generation cephalosporin, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis, making it effective against various gram-positive and gram-negative pathogens. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. The synergistic action of these two agents enhances the antibacterial efficacy, particularly in infections where mixed bacterial flora or resistant strains are suspected. Macpod O is indicated for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections caused by susceptible organisms. It is essential to use this medication under medical supervision, adhering to prescribed dosages and duration to prevent antibiotic resistance. Patients with known hypersensitivity to cephalosporins or fluoroquinolones should avoid this medication. Caution is advised in individuals with renal or hepatic impairment. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions. Macpod O 200 mg/200 mg Tablet offers an effective therapeutic option for managing complex bacterial infections requiring combination antibiotic therapy.